Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 78Active not recruiting 8Withdrawn 5Unknown 5Recruiting 4Terminated 3Not yet recruiting 3

Sponsor Class

OTHER 91INDUSTRY 32NIH 7NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Leukemia 2Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1

Interventions

Radiotherapy 41Cisplatin 36Fluorouracil 17Paclitaxel 15Docetaxel 14Cyclophosphamide 14Carboplatin 14Filgrastim 13Doxorubicin 13Gemcitabine 11Etoposide 11Capecitabine 10Surgical Procedures, Operative 9Methotrexate 9Leucovorin 9Chemotherapy, Adjuvant 9Vincristine 8Peripheral Blood Stem Cell Transplantation 8Oxaliplatin 8Dexamethasone 7Bevacizumab 7Topotecan 6Radiotherapy, Conformal 6Prednisone 6Fenretinide 6Cetuximab 6Neoadjuvant Therapy 5Mitomycin 5Irinotecan 5Ifosfamide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × NETWORK × Cytarabine × Clear all
NCT00335140 2023-07-03

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Terminated
26 enrolled 11 charts
Lymphoid

Lymphoma

NCT01187810 2022-03-31

Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL

South Plains Oncology Consortium

Phase 1 Terminated
3 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003729 2012-09-24

Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
13 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡